In prior analyses of the effectiveness of methylprednisolone for the treatment of patients with
acute traumatic spinal cord injuries (TSCIs), the prognostic importance of patients' …

Previous meta-analyses of methylprednisolone (MPS) for patients with acute traumatic
spinal cord injuries (TSCIs) have not addressed confidence in the quality of evidence used …

Methylprednisolone has become widely used in the management of acute spinal cord injury
and is considered by many to represent a “standard of care.” This is largely based on the …

OBJECTIVE Methylprednisolone (MP) to treat acute traumatic spinal cord injury (ATSCI)
remains controversial since the release of the second National Acute Spinal Cord Injury …

Objective Due to the continuing debates on the utility of high-dose methylprednisolone (MP)
early after acute spinal cord injury (ASCI), we aimed to evaluate the therapeutic and adverse …

Background: A systematic review of the evidence pertaining to methylprednisolone infusion
following acute spinal cord injury was conducted in order to address the persistent confusion …

BACKGROUND CONTEXT: Methylprednisolone has evolved during the 1990s, through the
results obtained from the National Acute Spinal Cord Injury Studies NASCIS II and III, as a …

Study design: Systematic literature review for primary data using predefined inclusion,
exclusion and validity criteria. Primary outcome measure was standardised neurological …

© 2003 Canadian Medical Association or its licensors tant functional gain, especially for
patients with cervical spinal cord injuries. Therefore, even the small improvement observed …

Objectives. Randomized trials are widely recognized as providing the most reliable
evidence for assessing efficacy and safety of therapeutic interventions. This evidence base …